SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Global confidence in Israeli tech shines through mega-deals

Tom Artiom Alexandrovich receives "no special treatment" in Nevada after arrest for sex crimes

Blumberg Capital: "Ninety percent of companies we evaluate today are AI-focused"

Inside Nir Zuk’s departure and Palo Alto’s next gamble

More stories 24more

24more

Buzz

Most popular

Daily

Weekly

1

Palo Alto Networks founder Nir Zuk steps down, marking end of an era in cybersecurity

2

Armis raising hundreds of millions at over $5 billion valuation

3

The 83-year-old who sold his invention for $466 million, and still walks to work every morning

4

“Startups in Portugal and Israel are in a similar situation because the local market is not big enough”

5

AppsFlyer in advanced talks to be acquired at over $3.5 billion valuation

Buzzmore

TrialJectory

1 stories about TrialJectory

צביה באדר מנכל TrialJectory

This Startup Helps Patients Find their Best Shot at Surviving Cancer

04.11.18|Tofi Stoler

When her mother was diagnosed with terminal cancer, entrepreneur Tzvia Bader realized finding the right treatment could become a full-time job. After her own brush with cancer, Bader co-founded TrialJectory, a startup that helps patients find the right treatment for them